Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 85Recruiting 33Terminated 21Active not recruiting 14Unknown 12Withdrawn 6Not yet recruiting 6Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 21Gastrointestinal 15Other solid neoplasm 14Lymphoid 14Genitourinary 11CNS 11Breast 10Tumor-Agnostic 9Thoracic 9Gynecologic 8Dermatologic 7Sarcoma 6Myeloid 6Head & Neck 4Plasma cell 1Endocrine 1Classical hematology 1

Conditions

Thyroid Carcinoma, Anaplastic 1Neoplasms 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Suspended × Endocrine × Clear all
NCT04418167 2025-09-03

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

JS InnoPharm, LLC

Phase 1 Suspended
71 enrolled
DermatologicEndocrineHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡